413 related articles for article (PubMed ID: 34535985)
21. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
Lin YC; Chang PF; Chang MH; Ni YH
Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
[TBL] [Abstract][Full Text] [Related]
22. Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans.
Ericson E; Bergenholm L; Andréasson AC; Dix CI; Knöchel J; Hansson SF; Lee R; Schumi J; Antonsson M; Fjellström O; Nasr P; Liljeblad M; Carlsson B; Kechagias S; Lindén D; Ekstedt M
Hepatol Commun; 2022 Oct; 6(10):2689-2701. PubMed ID: 35833455
[TBL] [Abstract][Full Text] [Related]
23. A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease.
Moon S; Chung GE; Joo SK; Park JH; Chang MS; Yoon JW; Koo BK; Kim W
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):682-691.e8. PubMed ID: 33905771
[TBL] [Abstract][Full Text] [Related]
24. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.
Zusi C; Mantovani A; Olivieri F; Morandi A; Corradi M; Miraglia Del Giudice E; Dauriz M; Valenti L; Byrne CD; Targher G; Maffeis C
Dig Liver Dis; 2019 Nov; 51(11):1586-1592. PubMed ID: 31255630
[TBL] [Abstract][Full Text] [Related]
25. Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.
Jiang ZG; Tapper EB; Kim M; Connelly MA; Krawczyk SA; Yee EU; Herman MA; Mukamal KJ; Lai M
J Clin Gastroenterol; 2018; 52(5):444-451. PubMed ID: 28362682
[TBL] [Abstract][Full Text] [Related]
26. Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study.
Krawczyk M; Stachowska E; Milkiewicz P; Lammert F; Milkiewicz M
Digestion; 2016; 93(2):139-48. PubMed ID: 26745555
[TBL] [Abstract][Full Text] [Related]
27. Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.
Trépo E; Caruso S; Yang J; Imbeaud S; Couchy G; Bayard Q; Letouzé E; Ganne-Carrié N; Moreno C; Oussalah A; Féray C; Blanc JF; Clément B; Hillon P; Boursier J; Paradis V; Calderaro J; Gnemmi V; Nault JC; Guéant JL; Devière J; Archambeaud I; Vitellius C; Turlin B; Bronowicki JP; Gustot T; Sutton A; ; Ziol M; Nahon P; Zucman-Rossi J
Lancet Oncol; 2022 Jan; 23(1):161-171. PubMed ID: 34902334
[TBL] [Abstract][Full Text] [Related]
28. The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency.
Shao X; Uojima H; Arai T; Ogawa Y; Setsu T; Atsukawa M; Furuichi Y; Arase Y; Horio K; Hidaka H; Nakazawa T; Kako M; Kagawa T; Iwakiri K; Nakajima A; Terai S; Tanaka Y; Koizumi W
Dig Dis; 2022; 40(5):625-634. PubMed ID: 34808618
[TBL] [Abstract][Full Text] [Related]
29. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
30. APOC3rs2854116, PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD: A meta-analysis.
Tong M; Wang F
IUBMB Life; 2020 Aug; 72(8):1757-1764. PubMed ID: 32525256
[TBL] [Abstract][Full Text] [Related]
31. Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease.
Ghodsian N; Abner E; Emdin CA; Gobeil É; Taba N; Haas ME; Perrot N; Manikpurage HD; Gagnon É; Bourgault J; St-Amand A; Couture C; Mitchell PL; Bossé Y; Mathieu P; Vohl MC; Tchernof A; Thériault S; Khera AV; Esko T; Arsenault BJ
Cell Rep Med; 2021 Nov; 2(11):100437. PubMed ID: 34841290
[TBL] [Abstract][Full Text] [Related]
32. Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene.
Tan HL; Zain SM; Mohamed R; Rampal S; Chin KF; Basu RC; Cheah PL; Mahadeva S; Mohamed Z
J Gastroenterol; 2014 Jun; 49(6):1056-64. PubMed ID: 23800943
[TBL] [Abstract][Full Text] [Related]
33. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
[TBL] [Abstract][Full Text] [Related]
34. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
Krawczyk M; Rau M; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Lammert F; Geier A;
J Lipid Res; 2017 Jan; 58(1):247-255. PubMed ID: 27836992
[TBL] [Abstract][Full Text] [Related]
35. TRIB1 rs17321515 and rs2954029 gene polymorphisms increase the risk of non-alcoholic fatty liver disease in Chinese Han population.
Liu Q; Xue F; Meng J; Liu SS; Chen LZ; Gao H; Geng N; Jin WW; Xin YN; Xuan SY
Lipids Health Dis; 2019 Mar; 18(1):61. PubMed ID: 30851741
[TBL] [Abstract][Full Text] [Related]
36. Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studies.
Zhao Y; Zhao W; Ma J; Toshiyoshi M; Zhao Y
Medicine (Baltimore); 2023 Mar; 102(10):e33110. PubMed ID: 36897668
[TBL] [Abstract][Full Text] [Related]
37. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
[TBL] [Abstract][Full Text] [Related]
38. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
Mancina RM; Dongiovanni P; Petta S; Pingitore P; Meroni M; Rametta R; Borén J; Montalcini T; Pujia A; Wiklund O; Hindy G; Spagnuolo R; Motta BM; Pipitone RM; Craxì A; Fargion S; Nobili V; Käkelä P; Kärjä V; Männistö V; Pihlajamäki J; Reilly DF; Castro-Perez J; Kozlitina J; Valenti L; Romeo S
Gastroenterology; 2016 May; 150(5):1219-1230.e6. PubMed ID: 26850495
[TBL] [Abstract][Full Text] [Related]
39. Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.
Kahali B; Halligan B; Speliotes EK
Semin Liver Dis; 2015 Nov; 35(4):375-91. PubMed ID: 26676813
[TBL] [Abstract][Full Text] [Related]
40. IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease.
Park J; Zhao Y; Zhang F; Zhang S; Kwong AC; Zhang Y; Hoffmann HH; Bushweller L; Wu X; Ashbrook AW; Stefanovic B; Chen S; Branch AD; Mason CE; Jung JU; Rice CM; Wu X
J Hepatol; 2023 Jan; 78(1):45-56. PubMed ID: 36049612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
